(Q43782374)

English

Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men.

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Fan YM

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Laaksonen R

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Janatuinen T

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Vesalainen R

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Nuutila P

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Lehtimäki T

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical Genetics

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

319-321

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

21 January 2018

Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

21 January 2018

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

21 January 2018

Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

21 January 2018

A common Ile796Val polymorphism of the human SREBP cleavage-activating protein (SCAP) gene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms modifying atherosclerotic disease - from lipids to vascular biology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600413.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-0004.2001.600413.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43782374&oldid=2103287083"